Up to 2014, within the scope of the European project "Electronic Health Records for Clinical Research" (EHR4CR), partners from academic research and industry will be jointly establishing a Europe-wide technology platform that aims to allow secondary use of data from electronic health records for the purpose of clinical research.
Today, lawyers, ethics specialists, and data protection experts from various EU member states are discussing in Berlin what legal and ethical issues will have to be addressed. The workshop is being organized by TMF, which – due to its extensive preliminary work on data protection and ethical issues of networked medical research – in this project is leading a work package dealing with the topic of data protection and data security.
Secondary use of data from electronic health records for the purpose of medical research could cut costs, speed up clinical research projects and make them more efficient. In particular, researchers could better identify suitable study patients – hitherto one of the major difficulties in planning and conducting clinical studies. Now a technological platform is to be created which will seamlessly integrate electronic health records into existing research platforms and networks in the health sector.
Legal Regulations in the EU Countries Vary Considerably
However, many legal and ethical issues still have to be clarified on the way. In particular, one of the reasons why the legal framework to which physicians, researchers and patients are exposed in the cross-border use of patient data for clinical research is uncertain is that the legal regulations and implemented legal practice concerning data protection and protection of the private domain vary substantially throughout the individual EU member states. For this reason, one work package in the EHR4CR project has the task of analyzing the current legal situations in the various member states of the EU and comparing them with one another. The aim is to provide recommendations as to how legal certainty can be created for clinical research when using the EU-wide technology platform.
At the workshop in Berlin on January 12 and 13, 2012, the legal situation in selected pilot countries is being presented: France, Great Britain, Scotland, and Germany. European researchers, lawyers and data protectionists will be jointly examining what points on the pathway of data from clinics to research are critical in legal terms.
One of the Largest Public-Private Partnership Projects in Europe
The EHR4CR project is being funded with a total of 17 million euros within the scope of the Innovative Medicines Initiative (IMI) over the period from 2011 to 2014. IMI is one of the largest public-private partnership projects in Europe with the aim of speeding up the development of better and safer medicinal drugs. The initiative is being jointly funded by the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
How to create video abstracts: Workshop for scientists at TIB on 27 January 2016
07.12.2015 | Technische Informationsbibliothek (TIB)
EuroVision - Museums Exhibiting Europe (EMEE): Fifth Smaller Meeting of the EU project
09.10.2015 | Universität Augsburg
Exceeding critical temperature limits in the Southern Ocean may cause the collapse of ice sheets and a sharp rise in sea levels
A future warming of the Southern Ocean caused by rising greenhouse gas concentrations in the atmosphere may severely disrupt the stability of the West...
Indications of light-induced lossless electricity transmission in fullerenes contribute to the search for superconducting materials for practical applications.
Superconductors have long been confined to niche applications, due to the fact that the highest temperature at which even the best of these materials becomes...
Researchers at King’s College London and the Wellcome Trust Sanger Institute in the United Kingdom have for the first time demonstrated a direct link between the Wbp2 gene and progressive hearing loss. The scientists report that the loss of Wbp2 expression leads to progressive high-frequency hearing loss in mouse as well as in two clinical cases of children with deafness with no other obvious features. The results are published in EMBO Molecular Medicine.
The scientists have shown that hearing impairment is linked to hormonal signalling rather than to hair cell degeneration. Wbp2 is known as a transcriptional...
Pollens, the bane of allergy sufferers, could represent a boon for battery makers: Recent research has suggested their potential use as anodes in lithium-ion batteries.
"Our findings have demonstrated that renewable pollens could produce carbon architectures for anode applications in energy storage devices," said Vilas Pol, an...
Automobiles increase the mobility of their users. However, their maneuverability is pushed to the limit by cramped inner city conditions. Those who need to...
09.02.2016 | Event News
02.02.2016 | Event News
26.01.2016 | Event News
09.02.2016 | Event News
09.02.2016 | Materials Sciences
09.02.2016 | Power and Electrical Engineering